{"entity":{"type":"insider","cik":"0001476971","url":"/insider/0001476971","json_url":"/insider/0001476971.json","name":"Thompson Jaye","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":21,"first":"2022-01-14","last":"2024-11-25","span_basis":"filed_date"},"name_variants":[{"name":"Thompson Jaye","source":"filing","n_filings":21,"first_seen":"2022-01-14","last_seen":"2024-11-25"}],"transactions":[{"id":2316833,"accession":"0001493152-24-047527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-047527","line_url":"/filing/0001493152-24-047527#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.91,"price_display":"12.91","price_state":"stated","total_value":12910.0,"total_display":"12,910.00","total_whole":"12,910","shares_owned_after":264148.0,"shares_owned_after_display":"264,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-25","scope":"insider"},{"id":2607988,"accession":"0001493152-24-036275","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-036275","line_url":"/filing/0001493152-24-036275#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":13.85,"price_display":"13.85","price_state":"stated","total_value":11080.0,"total_display":"11,080.00","total_whole":"11,080","shares_owned_after":263148.0,"shares_owned_after_display":"263,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-09-16","scope":"insider"},{"id":2055886,"accession":"0001493152-24-030163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-030163","line_url":"/filing/0001493152-24-030163#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":15.15,"price_display":"15.15","price_state":"stated","total_value":15150.0,"total_display":"15,150.00","total_whole":"15,150","shares_owned_after":262348.0,"shares_owned_after_display":"262,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-05","scope":"insider"},{"id":2159628,"accession":"0001493152-24-028606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-028606","line_url":"/filing/0001493152-24-028606#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":261348.0,"shares_owned_after_display":"261,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-22","scope":"insider"},{"id":7812827,"accession":"0001493152-23-038777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-038777","line_url":"/filing/0001493152-23-038777#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":4285.0,"total_display":"4,285.00","total_whole":"4,285","shares_owned_after":260348.0,"shares_owned_after_display":"260,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-27","filed_date":"2023-10-31","scope":"insider"},{"id":8208495,"accession":"0001493152-23-034479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034479","line_url":"/filing/0001493152-23-034479#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":5226.0,"total_display":"5,226.00","total_whole":"5,226","shares_owned_after":259848.0,"shares_owned_after_display":"259,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":8300406,"accession":"0001493152-23-024661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-024661","line_url":"/filing/0001493152-23-024661#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":9.49,"price_display":"9.49","price_state":"stated","total_value":2372.5,"total_display":"2,372.50","total_whole":"2,373","shares_owned_after":259248.0,"shares_owned_after_display":"259,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider"},{"id":8037122,"accession":"0001493152-23-015096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-015096","line_url":"/filing/0001493152-23-015096#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":2805.0,"total_display":"2,805.00","total_whole":"2,805","shares_owned_after":258998.0,"shares_owned_after_display":"258,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-02","scope":"insider"},{"id":7903270,"accession":"0001493152-23-011921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-011921","line_url":"/filing/0001493152-23-011921#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.87,"price_display":"11.87","price_state":"stated","total_value":11870.0,"total_display":"11,870.00","total_whole":"11,870","shares_owned_after":258745.0,"shares_owned_after_display":"258,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-12","scope":"insider"},{"id":8482419,"accession":"0001493152-23-007822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-007822","line_url":"/filing/0001493152-23-007822#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":3177.5,"total_display":"3,177.50","total_whole":"3,178","shares_owned_after":257745.0,"shares_owned_after_display":"257,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"},{"id":8447771,"accession":"0001493152-23-006138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-006138","line_url":"/filing/0001493152-23-006138#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":15.395,"price_display":"15.40","price_state":"stated","total_value":3848.75,"total_display":"3,848.75","total_whole":"3,849","shares_owned_after":257495.0,"shares_owned_after_display":"257,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-28","scope":"insider"},{"id":8496643,"accession":"0001493152-23-003766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-003766","line_url":"/filing/0001493152-23-003766#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":20.84,"price_display":"20.84","price_state":"stated","total_value":5210.0,"total_display":"5,210.00","total_whole":"5,210","shares_owned_after":257245.0,"shares_owned_after_display":"257,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-07","scope":"insider"},{"id":8632574,"accession":"0001493152-23-002849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-002849","line_url":"/filing/0001493152-23-002849#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":19.2,"price_display":"19.20","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":256995.0,"shares_owned_after_display":"256,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-30","scope":"insider"},{"id":8234020,"accession":"0001493152-23-001506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-001506","line_url":"/filing/0001493152-23-001506#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":4125.0,"total_display":"4,125.00","total_whole":"4,125","shares_owned_after":256745.0,"shares_owned_after_display":"256,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-17","scope":"insider"},{"id":6936512,"accession":"0001493152-22-035936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-035936","line_url":"/filing/0001493152-22-035936#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":3235.0,"total_display":"3,235.00","total_whole":"3,235","shares_owned_after":256495.0,"shares_owned_after_display":"256,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-20","scope":"insider"},{"id":6514375,"accession":"0001493152-22-034537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-034537","line_url":"/filing/0001493152-22-034537#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":13.98,"price_display":"13.98","price_state":"stated","total_value":3495.0,"total_display":"3,495.00","total_whole":"3,495","shares_owned_after":256245.0,"shares_owned_after_display":"256,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6483662,"accession":"0001493152-22-010484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-010484","line_url":"/filing/0001493152-22-010484#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":16.74,"price_display":"16.74","price_state":"stated","total_value":8370.0,"total_display":"8,370.00","total_whole":"8,370","shares_owned_after":255995.0,"shares_owned_after_display":"255,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":6697083,"accession":"0001493152-22-002817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-002817","line_url":"/filing/0001493152-22-002817#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":18.47,"price_display":"18.47","price_state":"stated","total_value":9235.0,"total_display":"9,235.00","total_whole":"9,235","shares_owned_after":255495.0,"shares_owned_after_display":"255,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-01","scope":"insider"},{"id":6483587,"accession":"0001493152-22-002021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-002021","line_url":"/filing/0001493152-22-002021#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":16.33,"price_display":"16.33","price_state":"stated","total_value":8165.0,"total_display":"8,165.00","total_whole":"8,165","shares_owned_after":254995.0,"shares_owned_after_display":"254,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-24","scope":"insider"},{"id":6483541,"accession":"0001493152-22-001542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-001542","line_url":"/filing/0001493152-22-001542#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg. Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg. Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg. Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":18.87,"price_display":"18.87","price_state":"stated","total_value":9435.0,"total_display":"9,435.00","total_whole":"9,435","shares_owned_after":254495.0,"shares_owned_after_display":"254,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-19","scope":"insider"},{"id":6820706,"accession":"0001493152-22-001189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-001189","line_url":"/filing/0001493152-22-001189#line-1","is_derivative":false,"issuer_cik":"0001476971","issuer_name":"Greenwich LifeSciences, Inc.","issuer_ticker":"GLSI","issuer_name_source":null,"issuer_url":"/issuer/0001476971","owner_cik":"0001476971","owner_name":"Thompson Jaye","owner_display_name":"Thompson Jaye","owner_url":"/insider/0001476971","role":"Officer (VP Clinical Reg. Affairs)","role_mark":"O","role_mark_label":"Officer (VP Clinical Reg. Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Clinical Reg. Affairs","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":19.99,"price_display":"19.99","price_state":"stated","total_value":19990.0,"total_display":"19,990.00","total_whole":"19,990","shares_owned_after":253995.0,"shares_owned_after_display":"253,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-13","filed_date":"2022-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001799788","name":"Greenwich LifeSciences, Inc.","url":"/issuer/0001799788","role":"Officer (VP Clinical Reg Affairs)","n_filings":21,"first_seen":"2022-01-14","last_seen":"2024-11-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001476971","retrieved_at":"2026-08-26T14:30:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}